Description

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) developed to interact with pituitary growth hormone signalling pathways within the endocrine system. In laboratory research environments, Tesamorelin has been studied for its involvement in growth hormone secretion mechanisms, metabolic signalling pathways, and endocrine regulatory processes.

Experimental investigations have examined Tesamorelin for its interaction with pituitary receptor activation pathways, insulin-like growth factor signalling, and metabolic hormone communication mechanisms. These pathways have made Tesamorelin a subject of interest in laboratory models exploring growth hormone axis regulation and metabolic signalling.

Research environments have also studied Tesamorelin in experimental models involving endocrine signalling, metabolic regulation pathways, and hormonal feedback mechanisms associated with the growth hormone system.

Supplied as a lyophilised peptide powder in sterile laboratory research vials.

Contents: 5mg Tesamorelin per vial

For laboratory research use only.
Not intended for human consumption or therapeutic use.